Home	Fast Track My Amedeo FAQ About	Flying Publisher
Fast Track	FPG #8: Alternative Treatments in Psychiatry FPG #7: Critical Care in Neurology	Free Medical Books

Hepatitis C

Free Subscription Articles published in Hepatogastroenterology Retrieve available abstracts of 37 articles: HTML format Text format

Single Articles

December 2011
1. HIRAOKA A , Hidaka S, Shimizu Y, Utsunomiya H, et al
   Recent Trends of Japanese Hepatocellular Carcinoma due to HCV in Aging Society.
   Hepatogastroenterology. 2011;59.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
2. UCCIFERRI C , Vecchiet J, Pizzigallo E, Falasca K, et al
   Optimization of Comorbidity Therapy to Achieve Sustained Viral Response in HCV Patients.
   Hepatogastroenterology. 2011;59.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   November 2011
3. MOMIYAMA K , Nagai H, Sumino Y
   Comparison of the Hemodynamics between Patients with Alcoholic or HCV-Related Cirrhosis.
   Hepatogastroenterology. 2011;58:2036-40.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   October 2011
4. ISHIKAWA T , Higuchi K, Kubota T, Seki KI, et al
   Combination PEG-IFN a-2b/Ribavirin Therapy Following Treatment of Hepatitis C Virus-Associated Hepatocellular Carcinoma is Capable of Improving Hepatic Functional Reserve and Survival.
   Hepatogastroenterology. 2011;59.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   September 2011
5. MIYASAKA A , Kumagai I, Abe K, Suzuki K, et al
   Viral Decline Over 48h and HCV Amino Acid Mutations are Related to Efficacy of PEG-IFN/Ribavirin.
   Hepatogastroenterology. 2011;59.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
6. AHMAD F , Che Hamzah NA, Mustaffa N, Hua GS, et al
   CYP3A4*18 polymorphisms and anti-hepatitis A virus seroprevalence.
   Hepatogastroenterology. 2011;58.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   August 2011
7. DANG SS , Wang WJ, Wang XF, Li YP, et al
   Telaprevir for Chronic Hepatitis C with Genotype 1: A Meta-Analysis.
   Hepatogastroenterology. 2011;59.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   July 2011
8. SINN DH , Kim J, Shin SR, Gwak GY, et al
   Ribavirin Dose and Treatment Outcome of Korean Patients with Genotype 1 Chronic Hepatitis C.
   Hepatogastroenterology. 2011;59.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
9. PARK JJ , Park JY, Kim do Y, Park YN, et al
   Prediction of Significant Fibrosis in Chronic Hepatitis C Patients with Normal ALT.
   Hepatogastroenterology. 2011;58:1321-7.
   PubMed     Text format     Related articles    Abstract available
   
   
   
   
10. COBAN S , Idilman R, Erden E, Tuzun A, et al
    Gamma-glutamyltranspeptidase in predicting sustained virological response in individuals with chronic hepatitis C.
    Hepatogastroenterology. 2011;58:1301-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
11. MIHAILA RG , Nedelcu L, Fratila O, Retzler L, et al
    Effects of simvastatin in patients with viral chronic hepatitis C.
    Hepatogastroenterology. 2011;58:1296-300.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
12. VELOSA J , Serejo F, Bana T, Redondo I, et al
    Chronic Hepatitis C Treated with Peginterferon alfa plus Ribavirin in Clinical Practice.
    Hepatogastroenterology. 2011;58:1260-6.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
13. CHOI Y , Jeon WK, Hwang SJ, Kim BI, et al
    The role of the gut barrier function in the pathophysiology of viral liver cirrhosis.
    Hepatogastroenterology. 2011;58:1244-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2011
14. OHKOSHI S , Yamagiwa S, Yano M, Takahashi H, et al
    Failure to achieve 2-log10 viral decrease in first four weeks of peg-IFNalpha-2b plus ribavirin therapy for chronic hepatitis C with genotype 1b and high viral titer is useful in predicting non-response: evaluation of response-guided therapy.
    Hepatogastroenterology. 2011;58.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
15. MOHAMAD HI , El-Bab HK, Kamal AM
    HCV RNA in serum and peripheral blood mononuclear cells after successful interferon therapy.
    Hepatogastroenterology. 2011;58.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
16. WANG CH , Mo LR, Chang KK, Lin RC, et al
    A cohort study to investigate hepatocellular carcinoma risk in hepatitis C patients.
    Hepatogastroenterology. 2011;58.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
17. AL-ALI J , Al-Mutari N, Ahmed el-SF
    Hepatitis C virus and the skin.
    Hepatogastroenterology. 2011;58.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
18. TASKOPARAN M , Serin E, Gokturk HS, Icer MO, et al
    Early effect of peginterferon alpha-2b plus ribavirin treatment on blood pressure and insulin resistance in patients with chronic hepatitis C.
    Hepatogastroenterology. 2011;58.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2011
19. TESTINO G , Sumberaz A, Ansaldi F, Borro P, et al
    Treatment of recurrent hepatitis C (genotype 1) with pegylated interferon alfa-2b and ribavirin combination and maintenance therapy.
    Hepatogastroenterology. 2011;58:536-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
20. CHEN WT , Macatula TC, Lin CC, Lin CJ, et al
    Diabetes may not affect outcomes in hepatocellular carcinoma after radio-frequency ablation.
    Hepatogastroenterology. 2011;58:551-7.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    January 2011
21. OHARA T , Oteki T, Suzuki T, Suzuki M, et al
    Efficacy of double filtration plasmapheresis with pegylated interferon/ribavirin therapy for intractable chronic hepatitis C patients and hepatitis C patients with combined liver cirrhosis by HBV, leading to early viral elimination.
    Hepatogastroenterology. 2011;58:133-6.
    PubMed     Text format     Related articles   
    
    
    
    
22. KAWAGUCHI T , Itou M, Taniguchi E, Sakata M, et al
    Serum level of free fatty acids is associated with nocturnal hypoglycemia in cirrhotic patients with HCV infection: a pilot study.
    Hepatogastroenterology. 2011;58:103-8.
    PubMed     Text format     Related articles   
    
    
    
    
23. OZENNE V , Gervais A, Peytavin G, Castelnau C, et al
    Suspected interaction between sorafenib and HAART in an HIV-1 infected patient: a case report.
    Hepatogastroenterology. 2011;58:161-2.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    November 2010
24. IRSHAD M , Ansari MA, Singh A, Nag P, et al
    HCV-genotypes: a review on their origin, global status, assay system, pathogenecity and response to treatment.
    Hepatogastroenterology. 2010;57:1529-38.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
25. TETSUTANI T , Adachi K, Suzuki T, Kiyohara S, et al
    Clinical study of urinary sulfated bile acids in patients with hepatitis C virus.
    Hepatogastroenterology. 2010;57:1483-8.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    September 2010
26. XING TJ , Xv HT, Zhao W, Shen L, et al
    Application of interferon response-related gene array to the antiviral treatment outcome in chronic hepatitis C.
    Hepatogastroenterology. 2010;57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
27. KONISHI I , Hiasa Y, Nonaka T, Hiraoka A, et al
    Prospective study of chronic hepatitis C treated with reduced initial ribavirin dose.
    Hepatogastroenterology. 2010;57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
28. KURODA H , Kakisaka K, Tatemichi Y, Sawara K, et al
    Non-invasive evaluation of liver fibrosis using acoustic radiation force impulse imaging in chronic hepatitis patients with hepatitis C virus infection.
    Hepatogastroenterology. 2010;57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
29. ZOU ZQ , Ding YP, Long B, Yuh JG, et al
    Gpc-3 is a notable diagnostic, prognostic and a latent targeted therapy marker in hepatocellular carcinoma.
    Hepatogastroenterology. 2010;57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
30. MORACE C , Spadaro A, Cucunato M, Tortorella V, et al
    High serum resistin in chronic viral hepatitis is not a marker of metabolic disorder.
    Hepatogastroenterology. 2010;57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    July 2010
31. GHEORGHE L , Baculea S
    Cost-effectiveness of peginterferon alpha-2a and peginterferon alpha-2b combination regimens in genotype-1 naive patients with chronic hepatitis C.
    Hepatogastroenterology. 2010;57:939-44.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
32. DABROWSKA MM , Panasiuk A, Flisiak R
    Thyroid dysfunction in antiviral therapy of chronic hepatitis C.
    Hepatogastroenterology. 2010;57:826-31.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
33. MENG QH , Yu HW, Li J, Wang JH, et al
    Inadequate nutritional intake and protein-energy malnutrition involved in acute and chronic viral hepatitis Chinese patients especially in cirrhosis patients.
    Hepatogastroenterology. 2010;57:845-51.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
34. GULSEN MT , Beyazit Y, Guclu M, Koklu S, et al
    Testing for hepatitis B and C virus infection before upper gastrointestinal endoscopy: justification for dedicated endoscope and room for hepatitis patients.
    Hepatogastroenterology. 2010;57:797-800.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    May 2010
35. TSENG KC , Chang CK, Chou AL, Hsieh YH, et al
    Prognostic effect of human leukocyte antigen class I and II alleles on chronic hepatitis C patients treated by pegylated interferon-alfa plus ribavirin in Taiwan.
    Hepatogastroenterology. 2010;57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    
36. YONEM O , Arslan S, Sokmensuer C, Salmanzade S, et al
    Can angiogenesis be a target of treatment for ribavirin associated hemolytic anemia?
    Hepatogastroenterology. 2010;57.
    PubMed     Text format     Related articles    Abstract available
    
    
    
    March 2010
37. FARIAS A , Re V, Mengarelli S, Kremer L, et al
    Detection of hepatitis C virus (HCV) in body fluids from HCV monoinfected and HCV/HIV coinfected patients.
    Hepatogastroenterology. 2010;57:300-4.
    PubMed     Text format     Related articles    Abstract available
    
    
    

Thank you for your interest in scientific medicine.

This service is provided by AMEDEO through an unrestricted educational grant from F. Hoffmann-La Roche.

Amedeo is a Flying Publisher website.    Design: